The Beauty Health Company (SKIN): Analyst Consensus Forecast

The Beauty Health (SKIN) business is fighting for the attention of aesthetic centers amid intense pressure from low-cost Eastern replicas. A closed B2B network, where equipment owners are required to purchase original formulations, guarantees revenue stability. This daily price chart, which currently shows a level of 14.04, prices in the risks of outsourcing circuit board assembly and serum production to third-party contractors.

Beauty Health (SKIN): Price Target Chart from 07/04/2022 to 11/12/2026

Metric breakdowns and analytics for The Beauty Health (SKIN)

- price and consensus price forecast:

Market Chart beautyhealth.com|SKIN - Price Target Chart

- stock exchange capitalization data:

Market Capitalization Beauty Health|SKIN - Enterprise Value

- balance sheet equity data:

Net Assets per Share BeautyHealth|SKIN - Company Book Value|Capitalization to Book Value Ratio beautyhealth.com|SKIN - Cumulative Company Assets

- debt obligations and liquidity statistics:

- net income and valuation ratios data:

SKIN - Company Net Income|Future Profit The Beauty Health|SKIN - P/E Multiple|Projected Price to Earnings Ratio beautyhealth.com|SKIN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Beauty Health|SKIN - Operating profit before deduction of amortization|Earnings per share for the last four quarters BeautyHealth|SKIN - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months beautyhealth.com|SKIN - Earnings growth in current year|Expected earnings per share trend next year The Beauty Health

General company analysis:SKIN - The Beauty Health Company

The dominance of HydraFacial technology within the B2B aesthetic medicine segment establishes a resilient foundation for the capitalization of The Beauty Health (SKIN). The trend in the average fair value estimate reflects consolidated investment bank calculations, enabling investors to compare the market price with the business's intrinsic potential and assess the speed of target adjustments via the line's slope to minimize overpayment risks.

Competing companies